Literature DB >> 6335422

Clinical profiles of patients with antibodies to nuclear ribonucleoprotein.

J Calderon, V Rodriguez-Valverde, S Sanchez Andrade, J L Riestra, J Gomez-Reyno.   

Abstract

Currently there are no widely accepted criteria for the diagnosis of MCTD. In this work we attempted to define the clinical profile of a group of 68 patients with anti nRNP antibodies, detected by immunoprecipitation in 0.6% agarose. The diagnosis of each collagen vascular disease was established in every patient, who met with the strict diagnostic criteria either at clinical presentation or during the follow-up period. Twenty-eight patients had SLE, 9 had classical erosive RA, three had PSS and one had PM. The only distinctive features in the group of SLE with anti nRNP was an increased incidence of anti Sm antibodies (p less than 0.05). In the RA group there was a trend towards a high frequency of Raynaud's phenomenon and swollen hands. At clinical presentation twenty-seven patients did not fulfil enough criteria to be diagnosed of any of the well-defined collagen vascular disease. They presented an undifferentiated syndrome, characterized clinically by Raynaud's phenomenon (100%), swollen hands (88.9%) and joint symptoms (88.9%), with scarce tendency of developing severe systemic manifestations. The main laboratory abnormalities in this group were hypergammaglobulinemia, mildly increased ESR, abnormal levels of CIC, negative anti nDNA and anti Sm antibodies, and the virtual absence of hypocomplementemia. During a clinical course of 96 +/- 72.5 months only one patient evolved into another collagen disease (SLE). The clinical course in the remaining cases, was stable improving with low doses of prednisone and/or NSAID. We suggest considering this undifferentiated syndrome as a distinct entity, for which the already classical term of MCTD could be reserved.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335422     DOI: 10.1007/bf02031271

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  54 in total

1.  Immune-complex glomerulonephritis in a patient with mixed connective tissue disease.

Authors:  T J Fuller; A V Richman; D Auerbach; R W Alexander; R Lottenberg; S Longley
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

2.  Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis.

Authors:  M Weisman; N Zvaifler
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.

Authors:  D M Grennan; C Bunn; G R Hughes; W W Buchanan; W C Dick
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

4.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

5.  Conversion of discoid lupus erythematosus to mixed connective tissue disease.

Authors:  J N Gilliam; S D Prystowsky
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

6.  Interactions of extractable nuclear antigen (ENA) and double stranded DNA.

Authors:  M Hamburger; L Friedlander; P Barland
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

7.  The detection and identification of antibodies to saline extractable nuclear antigens by counterimmunoelectrophoresis.

Authors:  H D Keiser; J Weinstein
Journal:  Arthritis Rheum       Date:  1980-09

8.  Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

Authors:  G C Sharp; W S Irvin; C M May; H R Holman; F C McDuffie; E V Hess; F R Schmid
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

9.  Circulating immune complexes in mixed connective tissue disease.

Authors:  J T Halla; J E Volanakis; R E Schrohenloher
Journal:  Arthritis Rheum       Date:  1979-05

10.  An appraisal of tests for native DNA antibodies in connective tissue diseases. Clinical usefulness of Crithidia luciliae assay.

Authors:  A Chubick; R D Sontheimer; J N Gilliam; M Ziff
Journal:  Ann Intern Med       Date:  1978-08       Impact factor: 25.391

View more
  5 in total

Review 1.  The use of laboratory tests in the diagnosis of SLE.

Authors:  W Egner
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

2.  The association of Raynaud's syndrome with rheumatoid arthritis--a meta-analysis.

Authors:  Peter Hartmann; Melvin Mohokum; Peter Schlattmann
Journal:  Clin Rheumatol       Date:  2011-04-02       Impact factor: 2.980

3.  The B cell repertoire in patients with systemic autoimmune diseases: analysis of Epstein-Barr virus (EBV)-inducible circulating precursors that produce autoantibodies against nuclear ribonucleoprotein (nRNP).

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Sumiya; R Yokohari
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

4.  Follow-up of 151 patients with high-titer U1RNP antibodies.

Authors:  P B Frandsen; N J Kriegbaum; S Ullman; M Høier-Madsen; A Wiik; P Halberg
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

5.  Morphoea (localised scleroderma) in a patient with mixed connective tissue disease.

Authors:  D N Golding
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.